Dutch firm that licensed OHSU tech gets $31M infusion
August 05, 2020 at 18:14 PM EDT
Vico Therapeutics focuses on RNA modulating therapies for rare neurological diseases.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|